Here’s our full breakdown of CBD and it’s wonderful medicinal benefits.
It was recently reported by Natural News that the FDA intends to ban CBD as a nutritional supplement, and is “waging war” against this and all cannabis extracts. Why? Because “Big Pharma” has synthesized CBD and is beginning its push to having it approved as a new drug.
We’ve written these these posts to introduce you to CBD:
- Your top questions about CBD answered: What is it, how do you use it, and what formulas do we offer?*
- CBD and its interaction with our own body’s endo-cannabinoid system.
- 350+ scientific research articles on the potential benefits of CBD and 50 common health conditions.*
- CBD and its synergistic actions with safely-ingested essential oils and CO2 extracts.*
A Summary of the FDA & CBD Controversy
- CBD (cannabidiol) is the most abundant naturally-occurring cannabinoid in 100% legal “industrial” hemp. This is the same plant which provides hemp seeds, hemp seed oil, hemp fiber and hemp protein.
- CBD has been positively researched for its benefits for a wide variety of health conditions in over 350 scientific studies, published in peer-reviewed journals.*
- CBD has been synthetically produced by GW Pharmaceuticals. This company had submitted application to the FDA for an Investigation as a New Drug (IND) in 2014.
- The FDA prohibits sale of a molecule or compound as a dietary supplement if an IND had been applied for prior to its marketing as a supplement.
- However, CBD was in fact marketed as a supplement long before an IND was applied for by GW Pharmaceuticals with the FDA.
CBD Research Results are Solid Enough for Big Pharma to Pursue it as a New Drug
CBD has clearly demonstrated efficacy in reduction of epileptic seizures, with great safety, in a series of studies reported by the American Epilepsy Society in www.ScienceDaily.com. CBD has, in fact, shown promise in support of a great many health conditions*, and Big Pharma is eager to make a profit…and so is the FDA.
GW Pharmaceuticals has applied for a New Drug Investigation with its synthetic Cannabidiol for treatment of severe epilepsy in children. Both GW Pharmaceuticals and the FDA would like to see this proceed in the “normal” fashion. The reason why is obvious…
How the FDA Get’s Paid
In 2010, the total cost of review and approval of a new drug was approximately $500M. Yes, that’s right, about $500,000,000 dollars are paid by a drug company to the FDA for new drug review and approval. And there’s been a record number of new drug applications this last year than ever before. Approving new drugs is one of the primary ways the FDA stays in business, and it’s not about to let go of this income source anytime soon.
What, Now, is the Legal Status of CBD?
The controversy surrounding the banning of CBD as a nutritional supplement – and perhaps why CBD may actually remain available as a supplement – is that by the FDA’s own rules, it should be “legal” to sell in this manner. It remains to be seen what will result in this battle between the hemp industry and the FDA.
The FDA’s “crackdown” on CBD has been to send warning letters regarding labeling to the largest CBD distributors in the Country. It has, as of yet, left open the outright banning of sale of this ingredient. Because CBD is simply concentrated from 100% legal industrial hemp through CO2 distillation, it’s difficult to imagine its sale being stopped. The FDA can prevent it from being marketed as a supplement, though there will certainly be very significant resistance from the hemp and cannabis industries.
We are of course offering our CBD formulas, including ingestible essential oils and CO2 extracts which may work in concert with CBD.